Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients [Heart Failure]

ConclusionsAmong a large national cohort of human immunodeficiency virus–infected patients, TDF use was strongly associated with lower risk of incident HF. These findings warrant confirmation in other populations, both with TDF and the recently approved tenofovir alafenamide fumarate.

Source: JAHA:Journal of the American Heart Association - April 24, 2017 Category: Cardiology Authors: Chen, R., Scherzer, R., Hsue, P. Y., Jotwani, V., Estrella, M. M., Horberg, M. A., Grunfeld, C., Shlipak, M. G. Tags: Risk Factors, Cardiomyopathy, Heart Failure Original Research Source Type: research